PDLIM3

Chr 4

PDZ and LIM domain 3

Also known as: ALP

PDLIM3 encodes a protein that organizes actin filament arrays within muscle cells by binding to alpha-actinin-2 at the Z lines of skeletal muscle. Mutations cause myotonic dystrophy, a muscle disorder affecting skeletal muscle function. The gene is highly constrained against loss-of-function variants (pLI near 0), and inheritance pattern information is available in GeneReviews.

Summary from RefSeq, UniProt
Research Assistant →
0
Active trials
9
Pubs (1 yr)
58
P/LP submissions
0%
P/LP missense
1.22
LOEUF
Multiple*
Mechanism· predicted
Clinical SummaryPDLIM3
🧬
Gene-Disease Validity (ClinGen)
hypertrophic cardiomyopathy · ADLimited

Limited evidence — not for standalone diagnostic reporting

2 total gene-disease associations curated

Population Constraint (gnomAD)
Low constraint (pLI 0.00) — loss-of-function variants are relatively tolerated in the population.
📋
ClinVar Variants
58 unique Pathogenic / Likely Pathogenic· 271 VUS of 500 total submissions
📖
GeneReview available — PDLIM3
Authoritative clinical overview · Recommended first read
Open GeneReview ↗

Population Genetics & Constraint

gnomAD v4 — loss-of-function & missense intolerance

Tolerant — LoF & missense variants common in population
LoF Constraint
1.22LOEUF
pLI 0.000
Z-score 0.92
OE 0.75 (0.481.22)
Tolerant

Highly tolerant — LoF variants common in population

Missense Constraint
-0.02Z-score
OE missense 1.00 (0.901.12)
224 obs / 223.1 exp
Tolerant

Tolerant to missense variation

Observed / Expected Ratios
LoF OE0.75 (0.481.22)
00.351.4
Missense OE1.00 (0.901.12)
00.61.4
Synonymous OE1.07
01.21.6
LoF obs/exp: 12 / 16.0Missense obs/exp: 224 / 223.1Syn Z: -0.49
Curated Mechanism (G2P)Gene2Phenotype (DDG2P) ↗
limitedPDLIM3-related dilated cardiomyopathyOTHERAD
limitedPDLIM3-related hypertrophic cardiomyopathyOTHERAD
DN
0.76top 25%
GOF
0.80top 10%
LOF
0.3551th %ile

This gene has evidence for multiple mechanisms of pathogenicity (gain-of-function and dominant-negative). Both the Badonyi & Marsh prediction and the broader genomic evidence point to gain-of-function as the predominant mechanism. Different variants in this gene may act through different mechanisms — interpret in context of the specific variant.

GOFprediction above median
DNprediction above median

Note: In-silico variant effect predictors (SIFT, PolyPhen, REVEL, CADD) may underestimate pathogenicity of missense variants in genes with GOF or DN mechanisms. Consider functional evidence and clinical context.

Predictions from Badonyi M, Marsh JA. PLoS ONE. 2024;19(8):e0307312.

ClinVar Variant Classifications

500 submitted variants in ClinVar

Classification Summary

Pathogenic51
Likely Pathogenic7
VUS271
Likely Benign139
Benign18
Conflicting13
51
Pathogenic
7
Likely Pathogenic
271
VUS
139
Likely Benign
18
Benign
13
Conflicting

Curated Variants Distribution

Classified variants from ClinVar · 5 ACMG categories

ClassificationLoFMissense + InframeNon-codingSynonymousTotal
Pathogenic
0
0
51
0
51
Likely Pathogenic
0
0
7
0
7
VUS
13
211
46
1
271
Likely Benign
0
2
50
87
139
Benign
0
0
18
0
18
Conflicting
13
Total1321317288499

LoF = frameshift, stop gained/lost, canonical splice · Counts from ClinVar esearch · Updated hourly

View in ClinVar →

Protein Context — Lollipop Plot

PDLIM3 · protein map & ClinVar variants

Showing all ClinVar variants across the protein. Search a specific variant to highlight its position.

Clinical Trials

Active and recruiting trials from ClinicalTrials.gov

No active trials found for this gene.

Search ClinicalTrials.gov →
Clinical Literature
Open Research Assistant →